Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001846:Bone Development; D001862:Bone Resorption; D001842:Bone and Bones / Q000473:pathology*; D002113:Calcification, Physiologic / Q000187:drug effects; D002118:Calcium / Q000097:blood; D002119:Calcium Carbonate / Q000627:therapeutic use*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008903:Minerals / Q000378:metabolism*; D010010:Osteoclasts / Q000378:metabolism; D010011:Osteocytes / Q000473:pathology; D010014:Osteolysis / Q000473:pathology; D010281:Parathyroid Hormone / Q000276:immunology / Q000378:metabolism*; D010710:Phosphates / Q000097:blood; D011863:Radioimmunoassay; D014807:Vitamin D / Q000627:therapeutic use
D006887:Hydroxycholecalciferols; D008903:Minerals; D010281:Parathyroid Hormone; D010710:Phosphates; D014807:Vitamin D; D003404:Creatinine; D002119:Calcium Carbonate; D002118:Calcium